English   español  

Browsing by Author Noblejas-López, María del Mar

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
RightsPreviewIssue DateTitleAuthor(s)Type
openAccessactivity_BET-proteolysis_targeting_chimeric.pdf.jpg30-Aug-2019Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancerNoblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Albertoartículo
openAccessEvaluation_Noblejas_PV_Art2018.pdf.jpg28-Nov-2018Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor geneNoblejas-López, María del Mar; Morcillo-Garcia, Sara; Nieto-Jiménez, Cristina; Nuncia-Cantarero, Miriam; Győrffy, Balázs; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo
openAccessGenetic_Morcillo_Garcia_Art2019.pdf.jpg16-Apr-2019Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumorsMorcillo-Garcia, Sara; Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Pérez-Peña, Javier; Nuncia-Cantarero, Miriam; Győrffy, Balázs; Amir, Eitan; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Albertoartículo
openAccessinhibitcance.pdf.jpg2020Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancerNieto-Jiménez, Cristina; Galán-Moya, Eva María; Corrales-Sánchez, Verónica; Noblejas-López, María del Mar; Burgos, Miguel; Domingo, Beatriz; Montero, Juan Carlos CSIC ORCID; Gómez-Juárez, Mónica; Picazo-Martinez, Maria Granada; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo
openAccesspharmacance.pdf.jpg2020Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancerCorrales-Sánchez, Verónica; Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Pérez-Peña, Javier; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo